Design considerations of a hollow microneedle-optofluidic biosensing platform incorporating enzyme-linked assays

A hollow metallic microneedle is integrated with microfluidics and photonic components to form a microneedle-optofluidic biosensor suitable for therapeutic drug monitoring (TDM) in biological fluids, like interstitial fluid, that can be collected in a painless and minimally-invasive manner. The micr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of micromechanics and microengineering 2018-02, Vol.28 (2), p.24002
Main Authors: Ranamukhaarachchi, Sahan A, Padeste, Celestino, Häfeli, Urs O, Stoeber, Boris, Cadarso, Victor J
Format: Article
Language:English
Subjects:
biosensor
enzyme-linked assay
hollow microneedle
optofluidic sensing
therapeutic drug monitoring
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A hollow metallic microneedle is integrated with microfluidics and photonic components to form a microneedle-optofluidic biosensor suitable for therapeutic drug monitoring (TDM) in biological fluids, like interstitial fluid, that can be collected in a painless and minimally-invasive manner. The microneedle inner lumen surface is bio-functionalized to trap and bind target analytes on-site in a sample volume as small as 0.6 nl, and houses an enzyme-linked assay on its 0.06 mm2 wall. The optofluidic components are designed to rapidly quantify target analytes present in the sample and collected in the microneedle using a simple and sensitive absorbance scheme. This contribution describes how the biosensor components were optimized to detect in vitro streptavidin-horseradish peroxidase (Sav-HRP) as a model analyte over a large detection range (0-7.21 µM) and a very low limit of detection (60.2 nM). This biosensor utilizes the lowest analyte volume reported for TDM with microneedle technology, and presents significant avenues to improve current TDM methods for patients, by potentially eliminating blood draws for several drug candidates.
ISSN:0960-1317
1361-6439
DOI:10.1088/1361-6439/aa9c9c